Pediatr. praxi. 2015;16(2):108-112

Probiotics in pediatrics, what is proven and what is not yet confirmed

prof.MUDr.Jiří Nevoral, CSc.
Pediatrická klinika UK 2. LF a FN Motol, Praha

Probiotics have become very popular over the last two decades for the ability to influence intestinal microbiota composition and to

alter host epithelial and immunological responses. Certain probiotic interventions have shown promise in selected clinical conditions

where aberrant microbiota have been reported, such as acute infectious diarrhea, necrotising enterocolitis, irritable bowel syndrome

and prevention of atopic dermatitis. Conclusions are based on meta-analyses of double-blinded, placebo-controlled studies which can

only demonstrate the efficacy of probiotics in prevention and treatment of certain diseases.

Keywords: probiotics, microbiome, microbiota, prevention, gastrointestinal diseases

Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoral J. Probiotics in pediatrics, what is proven and what is not yet confirmed. Pediatr. praxi. 2015;16(2):108-112.
Download citation

References

  1. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health. 2014; 9(3): 584-671. Go to original source... Go to PubMed...
  2. Zbinden A, Zbinden R, Berger Ch. Case Series of Bifidobacterium longum Bacteremia in Three Preterm Infants on Probiotic Therapy. Neonatology 2015; 107: 56-59. Go to original source...
  3. Mihatsch WA, Braegger CP, Decsi T, et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr 2012; 31: 6-15. Go to original source...
  4. Sung V, Hiscock H, Mimi L K, et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 2014; 348: g2107. Go to original source... Go to PubMed...
  5. Mansfield JA, Bergin SW, Cooper, at al. Comparative probiotic strain efficacy in the prevention of eczema in infants and children: a systematic review and meta-analysis. Mil Med. 2014 Jun; 179 (6): 580-592. Go to original source...
  6. Fiocchi A, Pawankar R, Cuello-Garcia C, et al. Worl Allergy Organization-McMaster University Guidelines for Allergic Disease prevention (GLAD-P: Probiotics. World Allergy Oraganization Journal 2015; 8: 4. Go to original source...
  7. West CE, Hammarström ML, Hernell O. Probiotics in primary prevention of allergic disease-follow-up at 8-9 years of age. Allergy. 2013; 68(8): 1015-1020. Go to original source...
  8. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee, at al. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008; (4): CD006135. Go to original source...
  9. Braegger C, Chmielewska A, Decsi T, et al. ESPGHAN Committee on Nutrition. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr. 2011; 52(2): 238-250. Go to original source... Go to PubMed...
  10. Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther. 2011; 34(9): 1079-1087. Go to original source...
  11. Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2011; (11): CD004827. Go to original source...
  12. Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. 2013; 5: CD006095. doi: 10.1002/14651858.CD006095.pub3. Go to original source...
  13. Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014; 20(1): 21-35. Go to original source... Go to PubMed...
  14. Miele E, Pascarella F, Giannetti, at al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009; 104(2): 437-443. Go to original source...
  15. Guandalini S. Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne). 2014; 1: 23. Go to original source...
  16. Li S, Huang XL, Sui J, at al. Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children. Eur J Pediatr. 2014; 173(2): 153-161. Go to original source...
  17. Sazawal S, Dhingra U, Hiremath G, et al. Prebiotic and probiotic fortified milk in prevention of morbidities in children: community-based, randomized double-blind, controlled trial. PloS One (Randomized Controlled Trial Research Support, Non-U.S. Gov't) 2010; 5: e12164. Go to original source...
  18. Leyer GJ, Li S, Mubasher ME, et al. Probiotics effects on cold and influenza-like symptom incidence and duration in children. Pediatric (Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't) 2009, 124: e172-179. Go to original source...
  19. Kukkonen K, Savilahti E, Haahtela T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics. 2008; 122(1): 8-12. Go to original source... Go to PubMed...
  20. Kalliomäki M, Collado MC, Salminen S, et al. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008; 87(3): 534-538. Go to original source...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.